Hispanic and black children more likely to miss school due to eczema than white children

May 22, 2019

PHILADELPHIA - In a study that highlights racial disparities in the everyday impact of eczema, new research shows Hispanic and black children are more likely than white children to miss school due to the chronic skin disease. Researchers from the Perelman School of Medicine at the University of Pennsylvania examined more than a decade's-worth of data among children enrolled in a national eczema registry and found Hispanic children were most likely to have missed at least six days of school over six-month period due to their condition. Black children also saw higher probabilities of missed school days compared to white children. JAMA Dermatology published the findings today.

Eczema, or atopic dermatitis (AD), is a common inflammatory disease that causes red and itchy skin. It affects about 30 million Americans in total, including up to 20 percent of children in the United States, according to the Centers for Disease Control. It is more common among black children and slightly more common in Hispanic children when compared with whites. In addition to the physical impact, eczema is associated with negative psychological effects, including an increased likelihood of anxiety and depression.

"The effects of eczema are more than skin-deep, and studies have shown that the mental health and social impact of this condition can be significant - sometimes just as much or more than the physical - and may lead to a higher number of school days missed," said the study's lead author Joy Wan, MD, MSCE, a post-doctoral fellow and Instructor of Dermatology.

Building on that previous research, this study specifically looked at eczema-related school absenteeism by race and ethnicity. Researchers used data on 8,015 patients enrolled in the Pediatric Eczema Elective Registry (PEER) between November 2004 and July 2017. All patients were between the ages of 2 and 17 and had their AD diagnosed by a doctor. Overall, 241 of them (3.3 percent) missed six or more days of school over a six-month period, which meets the U.S. Department of Education's definition of chronic school absenteeism. When adjusted for demographic and other variables, data showed Hispanic children were 3.4 times more likely to be chronically absent due to AD than white children. Black children were 1.5 times more likely.

The PEER data are self-reported, and the authors say the children included in PEER may not represent the general population with eczema. They say more research is needed to better understand the link. However, they point out this adds to a growing body of work that uncovers disparities related to eczema, including their recent study showing black and Hispanic children are more likely to go to an emergency room and black children are less likely to see a dermatologist for their eczema than white children.

"Most people don't realize the serious impact eczema can have on a person's life, and our research shows minorities may be disproportionately affected," said the study's senior author Junko Takeshita, MD, PhD, MSCE, an assistant professor of Dermatology and Epidemiology. "We still have a lot to learn about eczema-related disparities but it's becoming increasingly clear that these disparities need to be addressed."
-end-
This study was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR068433, T32-AR007465, R01-AR069062, R01-AR070873), and a Dermatology Foundation Dermatologist Investigator Research Fellowship. While PEER is a study funded by Valeant Pharmaceuticals, Valeant had no role in this research.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $425 million awarded in the 2018 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center--which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report--Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 40,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live. Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine provided more than $525 million to benefit our community.

University of Pennsylvania School of Medicine

Related Eczema Articles from Brightsurf:

Vitamin D lessens symptoms of severe eczema in children
Vitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research & Perspectives.

TV ads for psoriasis and eczema medications portray few people of color
Commercials from pharmaceutical companies advertising medication to treat psoriasis and eczema lack people from racial and ethnic minorities, according to research from the Perelman School of Medicine at the University of Pennsylvania.

NIH-supported scientists demonstrate how genetic variations cause eczema
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.

Biomedical researchers get closer to why eczema happens
A new study from researchers at Binghamton University, State University of New York may help to peel back the layers of unhealthy skin -- at least metaphorically speaking -- and get closer to a cure.

Researchers uncover novel approach for treating eczema
Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder's debilitating effects.

Revving up immune system may help treat eczema
Studying eczema, researchers at Washington University School of Medicine in St.

Childhood eczema cannot be prevented by daily moisturiser use, study finds
Using moisturisers on newborn babies does not prevent eczema as previously thought, according to a major new study.

Atopic eczema linked to increase fracture risk in adults
Adults with atopic eczema could face a raised risk of fracture, with the risk increasing the more severe the condition, according to a new study published in the Journal of Allergy and Clinical Immunology.

Long-term dupilumab benefits adolescents with eczema
Results from a phase IIa open-label trial and a subsequent phase III open-label extension trial reinforce findings from an earlier short-term trial that adolescents with moderate-to-severe atopic dermatitis, or eczema, can experience significant improvements with dupilumab.

Multiple genes affect risk of asthma, hay fever and eczema
In a new study from SciLifeLab at Uppsala University, researchers have found a total of 141 regions (genes) in our genetic material that largely explain the genetic risk underlying asthma, hay fever and eczema.

Read More: Eczema News and Eczema Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.